tradingkey.logo
tradingkey.logo
Search

United Therapeutics Corp

UTHR
Add to Watchlist
500.350USD
-2.350-0.47%
Close 09-15 16:00ET
21.35BMarket Cap
17.09P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.47%

5 Days

+0.48%

1 Month

+0.12%

6 Months

-6.67%

Year to Date

+2.69%

1 Year

+24.12%

Key Figures

505.440Open
507.150High
37.20KVolume
17.09P/E TTM
15.75P/E Dynamic
--Dividend TTM
0.09%Turnover Ratio
502.700Prev. Close
498.850Low
18.67MTurnover
17.86P/E Static
3.34P/B
0.00%Div Yield TTM
17.81%ROA
609.35052wk High
0.06Volume Ratio
1.20BNet Profit
42.68MShares
29.2723EPS TTM
0.58Beta
20.26%ROE
397.97052wk Low
1.64%Amplitude
85.12%Gross Margin
21.35BMarket Cap
-3.05Reward/Risk
2.07%Risk Rate
Recent
Earnings
More news coming soon, stay tuned...

United Therapeutics Corp's Score

0.03vs previous score
Forecast8.13
Financial Health9.22
Technical3.28
Valuation Dimensions8.21
Institutional Confidence10.00
Risk Assessment9.09

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
652.378Target Price
+31.23%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy44445555
Buy99997665
Hold33334445
Sell00000000
Strong Sell00000000

United Therapeutics Corp Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
7.82/6.83
Revenue / Forecast
783.30M/805.65M

United Therapeutics Corp Profile

SectorPharmaceuticals
Ticker SymbolUTHR
Number of employees1305
CountryUnited States of America

Ownership

ShareholdersProportion
BlackRock Institutional Trust Company, N.A.9.75%
Avoro Capital Advisors LLC6.14%
Wellington Management Company, LLP5.75%
Vanguard Portfolio Management, LLC4.72%
Shareholder TypesProportion
Investment Advisor42.28%
Investment Advisor/Hedge Fund39.53%
Hedge Fund10.32%
Pension Fund2.92%

FAQs

What is the current price of United Therapeutics Corp (UTHR)?

The current price of United Therapeutics Corp (UTHR) is 500.35.

What is the symbol of United Therapeutics Corp?

The ticker symbol of United Therapeutics Corp is UTHR.

What is the 52-week high of United Therapeutics Corp?

The 52-week high of United Therapeutics Corp is 609.35.

What is the 52-week low of United Therapeutics Corp?

The 52-week low of United Therapeutics Corp is 397.00.

What is the market capitalization of United Therapeutics Corp?

The market capitalization of United Therapeutics Corp is 21.35B.

Is United Therapeutics Corp (UTHR) currently rated as Buy, Hold, or Sell?

According to analysts, United Therapeutics Corp (UTHR) has an overall rating of Buy, with a price target of 652.38.

What is the Earnings Per Share (EPS TTM) of United Therapeutics Corp (UTHR)?

The Earnings Per Share (EPS TTM) of United Therapeutics Corp (UTHR) is 29.27.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.